301206 三元生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)0.6142.0942.3251.2235.778
总资产报酬率 ROA (%)0.5881.9822.1841.1575.033
投入资产回报率 ROIC (%)0.6032.0372.2331.1775.209

边际利润分析
销售毛利率 (%)16.66416.11811.1063.05014.055
营业利润率 (%)13.09316.17217.94711.70927.567
息税前利润/营业总收入 (%)13.63215.45116.57710.20518.896
净利润/营业总收入 (%)11.60714.05614.72211.20824.253

收益指标分析
经营活动净收益/利润总额(%)56.84832.05614.140-87.35749.978
价值变动净收益/利润总额(%)40.40666.28284.692189.98946.829
营业外收支净额/利润总额(%)0.0640.3680.2030.566-1.140

偿债能力分析
流动比率 (X)10.56018.34013.9041.4353.226
速动比率 (X)9.43216.86013.3190.9702.759
资产负债率 (%)4.2414.0676.5355.6665.116
带息债务/全部投入资本 (%)0.4620.4191.9903.4332.212
股东权益/带息债务 (%)21,252.92723,399.6754,850.0412,783.6894,380.713
股东权益/负债合计 (%)2,257.9242,358.8281,430.1231,664.8551,854.666
利息保障倍数 (X)25.677-19.783-11.787-6.498-2.260

营运能力分析
应收账款周转天数 (天)36.01156.19249.88646.74651.305
存货周转天数 (天)77.792104.82770.16774.75064.836